2026 Annual Meeting | S32 - General Neurology 1

Date Tuesday 04/21/26

Time 03:30 PM - 05:30 PM CDT Add To Calendar

Location McCormick Place West | W194b

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Scientific Platform Session

Moderator(s) Ameena Shafiq, MD, Sally V. Mathias, MD, FANA, FAES, FAAN

Topic(s) General Neurology

CME Available 2.00 CME credits

Program Materials Program Evaluations

Event Timeline
03:30 PM - 03:42 PM CDT	Abstract	001 - Interrelationship Between Body Mass Index, Venous Sinus Pressures, Craniospinal Elastance, and Intracranial Pressure in Idiopathic Intracranial Hypertension Hsiangkuo Yuan, MD, PhD
03:42 PM - 03:54 PM CDT	Abstract	002 - Associations Between Open Burn Pit Exposure and Neurological Disorders in Veterans Sarah Anthony, Other
03:54 PM - 04:06 PM CDT	Abstract	003 - CSF Immune Profiling Uncovers Disease-specific Inflammatory Patterns to Improve Neurological Diagnosis Raphael Bernard-Valnet, MD, PhD
04:06 PM - 04:18 PM CDT	Abstract	004 - A Lesion Network Mapping Study of the Cerebellar Lesion-related Impulsivity and Compulsivity Yicheng Lin, MD
04:18 PM - 04:30 PM CDT	Abstract	005 - High-throughput Proteomics in CSF and Plasma from ALS Patients Identifies Novel Biomarkers Related to Muscle Structure and Function Aparna Vasanthakumar, PhD
04:30 PM - 04:42 PM CDT	Abstract	006 - A Hidden Mimic: High Rate of Acute Nutritional Axonal Neuropathy Among Patients Initially Diagnosed with Guillain-Barré Syndrome Rachel Baumgartner, MS2
04:42 PM - 04:54 PM CDT	Abstract	007 - Phase 1b Study of the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Efficacy of ARGX-119 in Participants with DOK7 Congenital Myasthenic Syndromes Nancy L. Kuntz, MD, FAAN
04:54 PM - 05:06 PM CDT	Abstract	008 - Exploratory Post Hoc Analysis of Neutrophil-to-lymphocyte Ratio as a Novel Response Biomarker for Edaravone Oral Suspension-treated Patients with Amyotrophic Lateral Sclerosis vs Untreated Propensity Score-matched PRO-ACT Historical Placebo Controls Benjamin R. Brooks, MD, FAAN
05:06 PM - 05:18 PM CDT	Abstract	009 - Efficacy of Eplontersen According to Baseline Polyneuropathy Severity in Patients with Hereditary Transthyretin Amyloidosis: A Subgroup Analysis of the NEURO-TTRansform Index Study Thomas Brannagan III, MD, FAAN
05:18 PM - 05:30 PM CDT	Abstract	010 - Meeting of the Minds 2025: A Student-led Model for Advancing Neuroeducation Through Immersive and Inclusive Learning Annie Alocious

Faculty Disclosures
Benjamin R. Brooks, MD, FAAN	Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medicinova. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma America. The institution of Dr. Brooks has received research support from Mitsubishi TanabePharma America. Dr. Brooks has received personal compensation in the range of $0-$499 for serving as a Member Annual Surveillance Committee CDC National ALS Registry with Center for Disease Control Agency Toxic Substances Disease Registry. Dr. Brooks has a non-compensated relationship as a Member ALS Quality Measures Subcommittee with American Academy of Neurology that is relevant to AAN interests or activities.
Hanns Lochmuller, MD, FAAN	Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CCRM. Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Canada Inc. Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Satellos. Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for KYE Pharma. Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Lochmuller has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Satellos. Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi US. Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Santhera. Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Precision. Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
John Ney, MD, MPH, FAAN	Dr. Ney has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell. Dr. Ney has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Clinical Practice.
Sami L. Khella, MD, FAAN	Dr. Khella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ionis. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eidos.
Jacqueline Palace	Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono, Medimmune, Argenx, Janssen, AMgen, UCB, Roche, Novartis, Amplo, Alexion, . Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx, Sanofi. Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche, UCB, Alexion, Amgen. Dr. Palace has or had stock in Astra Zenica. The institution of Dr. Palace has received research support from Roche, AMPLO, Alexion, UCB,. argenx, amgen. Dr. Palace has received intellectual property interests from a discovery or technology relating to health care.
Thomas Brannagan III, MD, FAAN	Dr. Brannagan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Brannagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia. Dr. Brannagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zenica. Dr. Brannagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. The institution of Dr. Brannagan has received research support from Alnylam. The institution of Dr. Brannagan has received research support from Abcuro. The institution of Dr. Brannagan has received research support from Ionis. The institution of Dr. Brannagan has received research support from Vertex. The institution of Dr. Brannagan has received research support from NMD Pharma.
Nancy L. Kuntz, MD, FAAN	Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenyx. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Audentes Therapeutics. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Kuntz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. The institution of Dr. Kuntz has received research support from Argenx. The institution of Dr. Kuntz has received research support from Astellas. The institution of Dr. Kuntz has received research support from Biogen. The institution of Dr. Kuntz has received research support from Catalyst. The institution of Dr. Kuntz has received research support from Genentech. The institution of Dr. Kuntz has received research support from Scholar Rock. The institution of Dr. Kuntz has received research support from Regenx-Bio. The institution of Dr. Kuntz has received research support from Solid Biosciences. The institution of Dr. Kuntz has received research support from AMO. The institution of Dr. Kuntz has received research support from Novartis. The institution of Dr. Kuntz has received research support from BioHaven. Dr. Kuntz has received personal compensation in the range of $50,000-$99,999 for serving as a Sarepta Express post gene therapy advisor with Sarepta.
Angela L. Genge, MD	Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AL-S Pharma. Dr. Genge has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Genge has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Quralis. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Genge has received personal compensation in the range of $0-$499 for serving as a Consultant for WAVE. Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for eikonizo. Dr. Genge has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for rapa.
Marcia Waddington Cruz, MD	Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sobi. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NovoNordisk.
Sebastian F. Ameriso, MD	Dr. Ameriso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PHRI. Dr. Ameriso has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bayer, Boehringer, Abbott, AstraZeneca.
Michael J. Marmura, MD, FAAN	Dr. Marmura has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Marmura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. The institution of Dr. Marmura has received research support from Teva. The institution of Dr. Marmura has received research support from AbbVie. The institution of Dr. Marmura has received research support from Axsome. The institution of Dr. Marmura has received research support from Pfizer. Dr. Marmura has received publishing royalties from a publication relating to health care. Dr. Marmura has received publishing royalties from a publication relating to health care. Dr. Marmura has received publishing royalties from a publication relating to health care.
Sheng-Han Kuo, MD, FAAN	Dr. Kuo has nothing to disclose.
Renaud A. Du Pasquier, MD, FAAN	Dr. Du Pasquier has nothing to disclose.
Malco D. Rossi, MD	Dr. Rossi has nothing to disclose.
John L. Berk	John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam Pharmaceuticals. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis Pharmaceuticals. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca/IONIS. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eidos/BridgBio. John L. Berk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia Therapeutics. John L. Berk has received research support from Alnylam . John L. Berk has received research support from Ionis. John L. Berk has received research support from Eidos/Bridgbio.
Jason J. Sico, MD, FAAN	Dr. Sico has nothing to disclose.
Virginia A. Pujol Lereis, MD	Dr. Pujol Lereis has nothing to disclose.
Caroline Pot Kreis, MD	No disclosure on file
Sally V. Mathias, MD, FANA, FAES, FAAN	Dr. Mathias has or had stock in Abbvie Inc.Dr. Mathias has received personal compensation in the range of $100,000-$499,999 for serving as a neurologist with Department of Veterans Affairs (VHA).
Hsiangkuo Yuan, MD, PhD	An immediate family member of Dr. Yuan has received personal compensation for serving as an employee of Merck. Dr. Yuan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Yuan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Yuan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Yuan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Salvia. Dr. Yuan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovous. Dr. Yuan has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Regional Anesthesia and Pain Medicine. Dr. Yuan has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Headache and Pain Reports. Dr. Yuan has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Yuan has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Cephalalgia. The institution of Dr. Yuan has received research support from NIH. The institution of Dr. Yuan has received research support from American Headache Society. The institution of Dr. Yuan has received research support from Pfizer. Dr. Yuan has received publishing royalties from a publication relating to health care. Dr. Yuan has received publishing royalties from a publication relating to health care. Dr. Yuan has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH. Dr. Yuan has received personal compensation in the range of $10,000-$49,999 for serving as a Invited speaker with Chinese Stroke Association.
Chi-Ying (Roy) Lin, MD, FAAN	Dr. Lin has received research support from Texas Alzheimer's Research and Care Consortium (TARCC). Dr. Lin has received research support from CurePSP. Dr. Lin has received research support from Mike Hogg Fund. Dr. Lin has received research support from The Michael J. Fox Foundation Parkinson's Progression Markers Initiative (PPMI). Dr. Lin has a non-compensated relationship as a Secretary with Broadway for Ataxia Foundation (a 501 (c) (3) non-profit organization) that is relevant to AAN interests or activities.
Yu-Ting Chen, MD	Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam.
Yicheng Lin, MD	Dr. Lin has nothing to disclose.
Florencia Yorio	No disclosure on file
Reid Gooch	Reid Gooch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stryker. Reid Gooch has stock in Sonorus NV.
Stephen Apple	Stephen Apple has received personal compensation for serving as an employee of Mitsubishi Tanabe Pharma America, Inc.
Raphael Bernard-Valnet, MD, PhD	The institution of Dr. Bernard-Valnet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Juvisé. The institution of Dr. Bernard-Valnet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Bernard-Valnet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Dr. Bernard-Valnet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Bernard-Valnet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Bernard-Valnet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. The institution of Dr. Bernard-Valnet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merz. The institution of Dr. Bernard-Valnet has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Bernard-Valnet has received research support from Novartis Foundation. The institution of Dr. Bernard-Valnet has received research support from Helmut-Horten Foundation. The institution of Dr. Bernard-Valnet has received research support from Baasch-Medicus Foundation.
Rebecca Shilling	Rebecca Shilling has received personal compensation for serving as an employee of argenx pharmaceuticals. Rebecca Shilling has stock in argenx pharmaceuticals. Rebecca Shilling has received intellectual property interests from a discovery or technology relating to health care.
Laura Piera Obici	Laura Piera Obici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Laura Piera Obici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Laura Piera Obici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Laura Piera Obici has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BridgeBio. Laura Piera Obici has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZeneca. Laura Piera Obici has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnylam.
Ameena Shafiq, MD	Dr. Shafiq has nothing to disclose.
Sarah Anthony, Other	Ms. Anthony has nothing to disclose.
Bill Cho, MD, PhD	Dr. Cho has received personal compensation for serving as an employee of Calico. Dr. Cho has stock in Roche.
Amos Baruch	Dr. Baruch has received personal compensation for serving as an employee of Calico Life Science.
Maria Eugenia Sarandria	Maria Eugenia Sarandria has nothing to disclose.
Ramiro Salas	The institution of Ramiro Salas has received research support from VHA. The institution of Ramiro Salas has received research support from Wallace foundation.
Fumihiro Takahashi, PhD	Dr. Takahashi has nothing to disclose.
Ushirogawa Yoshiteru, MPH	Mr. Yoshiteru has nothing to disclose.
Manabu Hirai	Mr. Hirai has received personal compensation for serving as an employee of Mitsubishi Tanabe Pharma America.
Tonke van Bragt, MSc	The institution of Mrs. van Bragt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for argenx. Mrs. van Bragt has stock in argenx.
Sonya Patel, MD	Dr. Patel has nothing to disclose.
Roeland Vanhauwaert, PhD	Mr. Vanhauwaert has stock in argenx.
Tony Alocious	Mr. Alocious has nothing to disclose.
Maksym Pola, MD, PhD	Dr. Pola has received personal compensation for serving as an employee of Astrazeneca. Dr. Pola has stock in Astrazeneca.
Mathew a. Maurer, MD	Dr. Maurer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Maurer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Maurer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Maurer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intellia. Dr. Maurer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Maurer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Maurer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BridgeBIo.
Morie Gertz, MD	Dr. Gertz has received personal compensation for serving as an employee of AstraZeneca. Dr. Gertz has received personal compensation for serving as an employee of Al nylym. Dr. Gertz has received personal compensation for serving as an employee of Johnson Johnson. Dr. Gertz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for beigene. Dr. Gertz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. Dr. Gertz has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American board of Internal Medicine.
Ahmad Masri, MD	Dr. Masri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cytokinetics, BMS, BridgeBio, Pfizer, Ionis, Lexicon, Attralus, Alnylam, Haya, Alexion, Akros, Edgewise, Rocket, Lexeo, Prothena, BioMarin, AstraZeneca, Avidity, Neurimmune, and Tenaya.. The institution of Dr. Masri has received research support from Pfizer, Ionis, Attralus, and Cytokinetics.
Jonatan Nåtman, MSc Statistics	Mr. Nåtman has received personal compensation for serving as an employee of AstraZeneca.
Romica Kerketta, PhD	Dr. Kerketta has received personal compensation for serving as an employee of AbbVie. Dr. Kerketta has or had stock in AbbVie.
Aparna Vasanthakumar, PhD	Dr. Vasanthakumar has received personal compensation for serving as an employee of Abbvie. Dr. Vasanthakumar has or had stock in Abbvie.
Nicholas Seneca	Dr. Seneca has received personal compensation for serving as an employee of Abbvie. Dr. Seneca has stock in Abbvie .
Ming-Kai Pan, MD, PhD	The institution of Dr. Pan has received research support from National Science and Technology Council.
Zoe Ziperovich, Student	Miss Ziperovich has nothing to disclose.
Luciana Salama, MD	Dr. Salama has nothing to disclose.
SANTIAGO J. VOLMARO, MS	Mr. VOLMARO has nothing to disclose.
Adrian M. Kim, Jr.	Mr. Kim has nothing to disclose.
Hernan Chaves, MD	Mr. Chaves has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Entelai.
Annie Alocious	Miss Alocious has nothing to disclose.
Andrés P. Varani, Sr., PhD	Dr. Varani has nothing to disclose.
Theodore J. Kwoh, PhD	Mr. Kwoh has received personal compensation for serving as an employee of Ionis Pharmaceuticals Inc. Mr. Kwoh has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Ionis Pharmaceuticals Inc. Mr. Kwoh has stock in Ionis Pharmaceuticals Inc.
Elinor Laffargue, MPH	Miss Laffargue has nothing to disclose.
daniel rogers, PhD	Dr. rogers has nothing to disclose.
Rachel Wang, BA, BS	Ms. Wang has nothing to disclose.
Eunice Chang, PhD	Dr. Chang has received personal compensation for serving as an employee of PHAR (now ADVI).
Scott Keith, PhD	Prof. Keith has nothing to disclose.
KATE LYDEN, PhD	Ms. LYDEN has received personal compensation for serving as an employee of VivoSense.
Steve Gentleman, PhD	Prof. Gentleman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. The institution of Prof. Gentleman has received research support from Parkinson's UK. The institution of Prof. Gentleman has received research support from MSA Trust.
ALEJANDRO D. MUGGERI, Sr., MD	Dr. MUGGERI has nothing to disclose.
Susan D. Mathias, MPH	Ms. Mathias has nothing to disclose.
Robert T. Marcotte, PhD	Mr. Marcotte has received personal compensation for serving as an employee of VivoSense.
Rachel Baumgartner, MS2	Miss Baumgartner has nothing to disclose.
Yuichiro Kato	Mr. Kato has received personal compensation for serving as an employee of Mitsubishi Tanabe Pharma Corporation.
Ieuan clay, PhD	Dr. clay has nothing to disclose.
Valentine A. Bressoud	Mrs. Bressoud has nothing to disclose.
Fumiaki Tanaka, MD, PhD	Prof. Tanaka has nothing to disclose.
Veronica E. Navarrine Nasjleti, Medical Student	Dr. Navarrine Nasjleti has nothing to disclose.
Mathieu Canales	Mr. Canales has nothing to disclose.
Zhelong Liu, MD	Dr. Liu has nothing to disclose.
Tristan Born, MD	Mr. Born has nothing to disclose.
Matthieu PERREAU, PhD	Prof. PERREAU has nothing to disclose.
Anahita Bhathena, PhD	Dr. Bhathena has received personal compensation for serving as an employee of AbbVie. Dr. Bhathena has stock in AbbVie.
Jennifer Mollon, PhD	Dr. Mollon has received personal compensation for serving as an employee of AbbVie Deutschland GmbH & Co KG. Dr. Mollon has stock in AbbVie Inc.
Pascal Jabbour, MD	Prof. JABBOUR has nothing to disclose.
BLANCA D. DIEZ, MD	Dr. DIEZ has nothing to disclose.
Stavropoula I. Tjoumakaris, MD	Dr. Tjoumakaris has nothing to disclose.
Manali A. Phadke, MS	Miss Phadke has nothing to disclose.
Steven Burden	No disclosure on file
Stéphanie Dincq	No disclosure on file
Jamie Lim	No disclosure on file
Ching-Po Lin	No disclosure on file
Lorenzo Maggi	No disclosure on file
Hege Michiels	No disclosure on file
Melissa Skanderson	No disclosure on file
Willem Talloen	No disclosure on file
Yaya Zhai	No disclosure on file
Syed Raza	No disclosure on file